Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)Paul L. Wood, Giovanni Zuliani, Patrick Herling et al.|BBA Clinical|2015Cited by 61